- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Corus Entertainment Inc Q2 Loss Increases, Misses Estimates | ||
| Fr | Commerce Resources Agrees To Be Bought By Australia's Mont Royal; Terms Not Disclosed | ||
| Fr | Gemfields Group Expects Wider Loss In FY24, To Raise $30 Mln In Rights Issue; Stock Down | ||
| Fr | Basel Medical To Acquire Singapore's Bethesda Medical For Undisclosed Terms | ||
| Fr | Harvard Bioscience CFO Jennifer Cote Resigns; Names Mark Frost Interim CFO | ||
| Fr | Halozyme :FDA Oks Argenx' VYVGART Hytrulo Prefilled Syringe For Generalized Myasthenia Gravis & CIDP | ||
| Fr | Vantage Mobility Appoints Daryl Adams As CEO | ||
| Do | Allison Transmission Appoints Scott Mell As Chief Financial Officer | ||
| Do | OpenAI Countersues Elon Musk, Alleges Deliberate Sabotage And Harassment In AI Battle | ||
| Do | CarMax Shares Stock Plunges 16% Despite Q4 Earnings Growth | ||
| Do | Pasithea Therapeutics Stock Climbs 41% On Positive Clinical Safety Recommendation | ||
| Do | Mortgage Rates Stay Below 7% Mark For 12th Consecutive Week | ||
| Do | Daxor Submits 510(k) To FDA For Next-Gen Blood Volume Analyzer | ||
| Do | Terreno Realty Buys Property In Redmond For $9.3 Mln | ||
| Do | Cineverse Acquires U.S. Rights To The Things You Kill | ||
| Do | Red Cat Holdings Stock Drops 22% On $30 Mln Direct Offering Announcement | ||
| Do | Byrna Technologies Stock Rises 4% Following Strong Q1 Earnings Report | ||
| Do | Creative Media & Community Trust Board Approves 1:25 Reverse Stock Split, Stock Down | ||
| Do | Establishment Labs Reports Preliminary Q1 Sales Results | ||
| Do | SmartRent Says President And CEO Shane Paladin Steps Down | ||
| Do | Innovative Eyewear Announces EU Certification For Lucyd Armor Safety Glasses | ||
| Do | Marin Software: Board Approves Plan Of Dissolution And Liquidation | ||
| Do | Bank7 Corp. Q1 Income Drops, But Beats Estimates | ||
| Do | Nona Biosciences Inks Research Partnership With Atossa Therapeutics For Next-gen Breast Cancer Drugs | ||
| Do | Calidi Biotherapeutics Names Guy Travis Clifton Chief Medical Officer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
